Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration - Wikidata - awgldk - TriplyDB

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

http://www.wikidata.org/entity/Q28087637

about

Acute leukemia in children: A review of the current Indian data P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Biology of childhood acute lymphoblastic leukemia.CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.Is Erwinase Necessary for all Children With ALL and Allergic Reactions to E. coli Asparaginase?Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.Altered neutrophil immunophenotypes in childhood B‑cell precursor acute lymphoblastic leukemia.Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy.Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study.CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response.Increased Risk of Thai Childhood Acute Lymphoblastic Leukemia with the MiR196a2 T>C Polymorphism Quality improvement in pediatrics: past, present, and future.Novel insights and therapeutic interventions for pediatric osteosarcoma.Pediatric T-cell acute lymphoblastic leukemia.The development of targeted new agents to improve the outcome for children with leukemia.Is there such a thing as biocompatible peritoneal dialysis fluid?Disparities in Adolescents and Young Adults With Cancer Ph-like acute lymphoblastic leukemia.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review.Emergence of heterogeneity in acute leukemias.Novel therapy for childhood acute lymphoblastic leukemia.Inferior outcomes for black children with high risk acute lymphoblastic leukemia and the impact of socioeconomic variables.Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951.Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†.Treatment delay and the risk of relapse in pediatric acute lymphoblastic leukemia.Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia.Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.Treatment of children with acute lymphoblastic leukemia with risk group based intensification and omission of cranial irradiation: A Korean study of 295 patients.Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia.Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report.Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.

P2860

Q28066885-669B88D6-D8B7-41F7-AFE7-C5166499DD93 Q28078609-9C2B6113-CA39-4849-AD04-71BDC0914373 Q33441148-C6C4B37A-8A7C-4BBF-831B-72C4D79EE489 Q33557148-F0CEDEB6-BFDA-44CF-82F9-786B0EFB1234 Q33639994-5DB7AFC4-764C-40A3-9E94-E7ACFFB72DA9 Q33677392-F0EB5188-7D6A-4516-BE11-16E1C8F81A10 Q33761600-9B209C67-1EAA-4A70-B8C1-A07EDC44C113 Q34605953-8C333F2E-B46E-4955-B625-3C7D0F330F51 Q36056038-7E8F8A3F-9A27-4EB7-B0FC-BE0F03829E02 Q36586248-E60ED128-191F-46BC-8E93-8B757701D19E Q37035173-810A5C81-5AB3-467C-84F3-42DCFA19EAF3 Q37269402-DFB28EE6-FBBB-4AA2-81A2-1C14F7220E54 Q37619915-C1100569-ED67-49DC-A952-5A348B48E30D Q37677743-C7DFC98B-36BA-4CBD-AAA4-35E544DE4628 Q38643300-178425A3-82D4-40F2-946A-8CB427D72022 Q38644266-C6DDD3C7-26AC-4EEE-BE35-778C75AA918F Q38726062-A732964A-EAA5-47B9-B2BA-FEFA40536D96 Q38761913-7EA6EA67-E779-4FCA-B58E-4390ABE65C3B Q38805699-360FC66A-F090-4EE5-8B6C-82576E1F1819 Q38819276-CEAF7CAF-662A-41F7-A846-5CDC7C3CE7A3 Q38956273-07FF1AFA-D888-4CAD-9101-8978B64BC5B3 Q38964974-23FD8386-4ABC-443F-9F8B-068483A593A4 Q38976940-04EF1597-A46B-43A7-9584-43E3BA4F095F Q39008035-9FAA23C2-C436-438A-A915-07F46801D133 Q39027852-49CB9055-042E-47B6-9C21-1AFA0587627B Q39041475-998B855C-4C6E-4109-BF41-9EB928322208 Q39123286-ED24CF0C-A4DE-4848-882E-5BF002C598BA Q39165240-82D568EA-AF7C-448D-AC06-299178459C37 Q39298587-0756EFC3-9E20-423A-A3D7-DAE12F0B12B8 Q39368957-2EE66480-2B7B-4476-B765-6933D7CB0D33 Q39369458-E86F7492-E979-4180-81ED-7318E86A7143 Q40116316-E50F9BED-FD95-41AE-AF51-373421ADD9EB Q40227501-33C808E1-D8AA-4C41-B8F8-CDDAB31B893A Q40296977-3710D1FF-14BA-4E95-8199-2C9F69881CDB Q40360999-90DA1A57-836E-466E-8B41-E2C79452E868 Q40396529-441C911B-348F-4CA1-8A48-275A1B7CB9B1 Q40598104-5A75E4D0-95CA-47C2-A482-FB97F6D08818 Q41087485-705DAE5F-2BCA-4A25-9709-A913C6A10B4F Q41878956-F0D4D249-2FA2-4CCF-A3D1-B167C9358DDA Q42324924-3E6C19AE-CB60-4EB9-B1C9-604F91D0B145

P2860

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

http://www.wikidata.org/entity/Q28087637

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@ast

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@en

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@nl

type

label

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@ast

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@en

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@nl

prefLabel

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@ast

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@en

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@nl

P1433

Q28087637-0C52C982-DBF0-435C-992D-51AB7A8EE3D5

P1476

Q28087637-DE30EAFC-0F44-46F6-91B9-BB6B0EE38730

P2093

Q28087637-0BEE24A1-6405-4E0F-B4BD-A059E3DDEC7B

Q28087637-1B06BD64-9AEB-40AA-8743-352010CF22EC

Q28087637-33AF91AD-0D42-4A81-9C75-012630EA8E84

Q28087637-35446994-E7BE-44A7-BD60-E1C2E0F18D68

Q28087637-8A82971D-E28D-453E-9C1F-5BDB2B0E5789

Q28087637-8B186584-67DD-4AF0-85C8-78E3441D7C78

Q28087637-90879A51-8B9F-46F1-8040-73292F60CF7A

Q28087637-96207FCD-FC2C-40F2-A340-BBABE5256DB9

Q28087637-B29A240D-B950-417B-B8A4-849D5FD27BFB

Q28087637-C498EF92-6C01-45EF-BEE8-D90C2165B4C4

P2860

Q28087637-06A42056-F9B6-4D96-932C-C30D17E66878

Q28087637-09236630-E82B-4C42-BA2F-CDC440356F9B

Q28087637-09DEDB55-88B0-4366-B875-932A4D2B69FB

Q28087637-12E4AFF8-E625-4311-89D2-B835242AE972

Q28087637-15DF498D-E512-4A50-910F-C22F97DB0D9A

Q28087637-19BEC4C6-FF50-4679-B0D1-BBB24AC13CBA

Q28087637-1C110EAE-A833-4337-A0A7-94CD5E04E4F5

Q28087637-201FE960-3CC4-4480-BA6B-6658740674D8

Q28087637-219B24E9-558D-44AB-A317-E699A763366F

Q28087637-277DC805-0DF1-44FF-A64A-FE59C520145A

P304

Q28087637-33552F1B-215F-4D13-8ABF-0AE821CA6671

P31

Q28087637-FD8B3137-8221-4193-BE75-11F6CB26A33E

P3181

Q28087637-77A90A11-C6C3-4D41-BB75-309D808BB80E

P356

Q28087637-4EB6FB89-19C1-4EAC-95E2-E5E77D616197

P407

Q28087637-24CE20FA-1CAD-46CA-BC65-D74D70137709

P433

Q28087637-E844A009-3DE0-4FB5-8EA7-E2EB0677BEA7

P478

Q28087637-78720F13-F1A4-413B-9264-7C418E48C141

P577

Q28087637-3F055901-E7F8-4AFB-8392-FF98CB92AED3

P698

Q28087637-79419452-D357-47BD-8F9C-6606BCF5132D

P921

Q28087637-3310B9EA-9C90-42F0-BF5B-296FDEB3C4D2

Q28087637-CF8CEB19-2099-4A1D-A84C-A49EAAC5CF3F

P932

Q28087637-FE98EFE0-FF6B-4D8D-AEFF-0D62A834289F

P3181

P356

JCO.2014.59.1636

P1433

Journal of Clinical Oncology

P1476

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

@en

P2093

A. Baruchel

http://www.w3.org/2001/XMLSchema#string

A. Biondi

http://www.w3.org/2001/XMLSchema#string

A. E. J. Yeoh

http://www.w3.org/2001/XMLSchema#string

A. Vora

http://www.w3.org/2001/XMLSchema#string

C. G. Mullighan

http://www.w3.org/2001/XMLSchema#string

C.-H. Pui

http://www.w3.org/2001/XMLSchema#string

D.-C. Liang

http://www.w3.org/2001/XMLSchema#string

G. Escherich

http://www.w3.org/2001/XMLSchema#string

J. J. Yang

http://www.w3.org/2001/XMLSchema#string

J. R. Downing

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile

Germline genomic variants associated with childhood acute lymphoblastic leukemia

Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype

Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia

P304

2938-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1637015

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2014.59.1636

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26304874

http://www.w3.org/2001/XMLSchema#string

P921

P932

4567699

http://www.w3.org/2001/XMLSchema#string